Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump

• Novo Nordisk sales beat estimates, but the story wasn’t Ozempic

  Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.
  
  MarketWatch - 1h

• UBS shares retreat 6% as fourth-quarter profit beat, $3 billion buyback fail to impress

  UBS revealed plans for up to $3 billion of share repurchases over the course of 2025.
  
  CNBC - 1d

• Shares of fashion giant H&M drop as fourth-quarter sales miss estimates

  Shares of H&M dropped on Thursday after the world's second-largest retailer missed sales forecasts in the fourth quarter.
  
  CNBC - 5d

• Novo Nordisk shares pop on early-stage weight loss drug trial results

  The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
  
  CNBC - Jan. 24
• 

  Novo Nordisk Shares Surge on New Obesity Drug Results

  Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
  
  The Wall Street Journal - Jan. 24
• 

  Adidas Exceeds Profit Guidance After Sales Jump in Fourth Quarter

  The German sporting-goods company said its operating profit climbed to €1.34 billion last year from €268 million in 2023.
  
  The Wall Street Journal - Jan. 21

• Shares of Cartier owner Richemont jump 16% as sales rise in December quarter

  Cartier owner Richemont on Thursday reported a 10% increase in third quarter sales even as China demand weighed.
  
  CNBC - Jan. 16

More from CNBC

• Apple shares fall 3% in premarket after China reportedly considers probe into App Store practices

  China's market regulator is considering whether to open a formal probe into the iPhone giant's App Store fees and policies, Bloomberg reported.
  
  CNBC - 1h

• Alphabet shares drop as much as 9% on revenue miss, soaring AI investments

  Alphabet reported fourth-quarter earnings on Tuesday after the close of regular trading.
  
  CNBC - 9h

• TotalEnergies posts 21% drop in annual profit, targets buybacks of $2 billion per quarter in 2025

  French oil major TotalEnergies on Wednesday reported a sharp drop in full-year earnings, against a backdrop of lower crude prices and weak fuel demand.
  
  CNBC - 16m

• USPS temporarily suspends some inbound packages from China, Hong Kong

  The change comes after President Donald Trump announced new tariffs that also target a popular trade loophole, called "de minimis."
  
  CNBC - 6h

• Wall Street needs to take Trump more seriously, Jim Cramer says

  CNBC's Jim Cramer unpacked President Donald Trump's actions over the past few days.
  
  CNBC - 10h

More in Business

• TotalEnergies posts 21% drop in annual profit, targets buybacks of $2 billion per quarter in 2025

  French oil major TotalEnergies on Wednesday reported a sharp drop in full-year earnings, against a backdrop of lower crude prices and weak fuel demand.
  
  CNBC - 16m
• 

  Research Says Leaders Who Inspire Others to Greatness Always Show These 3 Qualities

  A Columbia Business School psychologist has identified three universal behaviors of the most inspiring leaders.
  
  Inc. - 25m

• ‘How do I shield my retirement savings?’ I’m worried about Trump’s trade war and Fed’s willingness to cut interest rates

  “I’ve been in the nonprofit world my entire career, so my 403(b) is less than $500,000.”
  
  MarketWatch - 26m

• ‘I’ve been named sole heir’: My father, 92, is a Korean War veteran and stays out until dawn playing poker. What can I do?

  “The family is mortgaged, likely for more than it is currently worth, to cover Dad’s back taxes and credit-card and gambling debts.”
  
  MarketWatch - 34m

• Trump, tariffs and your 401(k) — why it’s time to diversify

  Putting all your eggs in one basket is an especially bad idea now.
  
  MarketWatch - 40m